Literature DB >> 15877776

Cost of affective disorders in Europe.

P Andlin-Sobocki1, H-U Wittchen.   

Abstract

Mesh:

Year:  2005        PMID: 15877776     DOI: 10.1111/j.1468-1331.2005.01195.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


× No keyword cloud information.
  18 in total

1.  Antidepressant properties of aqueous macerate from Gladiolus dalenii corms.

Authors:  Gwladys Temkou Ngoupaye; Elisabeth Ngo Bum; Germain Sotoing Taiwe; Fleur Clarisse Okomolo Moto; Emmanuel Talla
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-11-02

2.  Preclinical and clinical characterization of the selective 5-HT(1A) receptor antagonist DU-125530 for antidepressant treatment.

Authors:  M C Scorza; L Lladó-Pelfort; S Oller; R Cortés; D Puigdemont; M J Portella; R Pérez-Egea; E Alvarez; P Celada; V Pérez; F Artigas
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

3.  Creatine, similarly to ketamine, affords antidepressant-like effects in the tail suspension test via adenosine A₁ and A2A receptor activation.

Authors:  Mauricio P Cunha; Francis L Pazini; Julia M Rosa; Ana B Ramos-Hryb; Ágatha Oliveira; Manuella P Kaster; Ana Lúcia S Rodrigues
Journal:  Purinergic Signal       Date:  2015-02-22       Impact factor: 3.765

4.  The cost of generalized anxiety disorder in primary care settings: results of the ANCORA study.

Authors:  Joan Rovira; Guillermina Albarracin; Luis Salvador; Javier Rejas; Eduardo Sánchez-Iriso; Juan M Cabasés
Journal:  Community Ment Health J       Date:  2012-04-08

5.  Three studies on self-report scales to detect bipolar disorder.

Authors:  Christopher J Miller; Sheri L Johnson; Thomas R Kwapil; Charles S Carver
Journal:  J Affect Disord       Date:  2010-08-08       Impact factor: 4.839

Review 6.  Cost-of-illness studies for bipolar disorder: systematic review of international studies.

Authors:  Huajie Jin; Paul McCrone
Journal:  Pharmacoeconomics       Date:  2015-04       Impact factor: 4.981

7.  Pattern of healthcare resource utilization and direct costs associated with manic episodes in Spain.

Authors:  Monica Tafalla; Luis Salvador-Carulla; Jerónimo Saiz-Ruiz; Teresa Diez; Luis Cordero
Journal:  BMC Psychiatry       Date:  2010-04-28       Impact factor: 3.630

8.  Quality of life among patients with bipolar disorder in primary care versus community mental health settings.

Authors:  Christopher J Miller; Kristen M Abraham; Laura A Bajor; Zongshan Lai; Hyungjin Myra Kim; Kristina M Nord; David E Goodrich; Mark S Bauer; Amy M Kilbourne
Journal:  J Affect Disord       Date:  2012-09-12       Impact factor: 4.839

Review 9.  Excess mortality in bipolar disorders.

Authors:  Christopher Miller; Mark S Bauer
Journal:  Curr Psychiatry Rep       Date:  2014-11       Impact factor: 5.285

10.  Cultural adaptation into Spanish of the generalized anxiety disorder-7 (GAD-7) scale as a screening tool.

Authors:  Javier García-Campayo; Enric Zamorano; Miguel A Ruiz; Antonio Pardo; María Pérez-Páramo; Vanessa López-Gómez; Olga Freire; Javier Rejas
Journal:  Health Qual Life Outcomes       Date:  2010-01-20       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.